Spanish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
niacin/infartarse
El enlace se guarda en el portapapeles.
13 resultados
Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
General objectives:
Evaluate the therapeutic efficacy in Mexican adults with dyslipidemia through the oral route use of L-carnitine + atorvastatin in comparison with the use of Atorvastatin, after six months of treatment.
Evaluate the safety of the medicines under study.
Hypothesis:
The combined use
Meta-analysis of Randomized Controlled Trials on Vitamins and Mineral Supplementation for CVD Prevention and Treatment
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
Search strategy:
A literature search of the Cochrane Library, Medline and PubMed will be conducted with the following search terms: "dietary supplements or supplement*" AND "cardiovascular disease or myocardial infarction or stroke or cardiovascular death or mortality or all-cause mortality or
Effect of Pitavastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
Randomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoprotein(a)
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
Lipoprotein(a) [Lp(a)] is an independent risk factor for cardiovascular disease. Non-medical treatment measures (e.g. dietary therapy or weight loss) can hardly influence Lp(a) plasma concentrations. Drug therapy has only limited influence, e.g. treatment with niacin. Statins are usually without
Low-Density Lipoprotein (LDL) Apheresis Using H.E.L.P. Therapy
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
H.E.L.P. therapy is indicated for use in treating patients with familial hypercholesterolemia (FH) who have undergone six months of optimal diet and drug therapy and whose LDL-C level remains > 300 mg/dl in the absence of CHD or > 200 mg/dl with documented CHD. These patients are divided into three
Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke Recovery
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
The investigators are interested in extended-release niacin (Niaspan®) and its potential restorative role after ischemic stroke. At Henry Ford Hospital in Detroit, Michigan, extended-release niacin (Niaspan®) has been shown to improve the functional outcomes of rats when administered during the
Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
Cardiovascular disease is one of the leading causes of morbidity and mortality in the United Kingdom (UK), as well as in the developed and the developing world. Finding new and safe treatments to reduce the burden of heart disease and strokes is therefore an important contribution to public health
Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
INTRODUCTION
BACKGROUND: In recent years, the need to achieve increasingly ambitious therapeutic goals for dyslipidemias has prompted the search for more potent pharmacological agents to lower circulating atherogenic lipoprotein concentrations and enhance reverse cholesterol transport (RCT). While
Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FULL PROTOCOL
1.0 SYNOPSIS The primary objective of this randomized, double blind, placebo controlled pilot study is to determine if therapies aimed at lowering LDL cholesterol (HMGCoA reductase inhibitor - simvastatin) or increasing HDL cholesterol (Niaspan) will induce regression of carotid
Niacin Plus Statin to Prevent Vascular Events
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND:
Coronary heart disease (CHD) remains the leading cause of death and disability in the Western world, with approximately 12.6 million individuals in the United States having a history of myocardial infarction (MI), angina, or both. There is mounting evidence that "conventional" therapies
Coronary Drug Project
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND:
Correlation of high levels of serum cholesterol with an increased incidence and prevalence of coronary heart disease (CHD) was demonstrated--prior to the inception of the Coronary Drug Project--repeatedly in prospective and cross-sectional epidemiological surveys (e.g., the Tecumseh
HDL-Atherosclerosis Treatment Study (HATS)
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND:
More than one-third of patients with coronary disease have "low" high density lipoprotein cholesterol (HDLc) levels (less than 35 mg/dl; United States 20th percentile) and "normal" low density lipoprotein cholesterol (LDLc) (less than 145; United States mean), a group for whom current
Arterial Disease Multifactorial Intervention Trial (ADMIT)
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND:
Multiple mechanisms are involved in the deposition of LDL-C into the arterial wall, and the prevention of such deposition as well as the removal of the LDL-particles. Further, there remain questions regarding what causes an existing plaque that has been stable for a long period of time
La base de datos de hierbas medicinales más completa respaldada por la ciencia
- Funciona en 55 idiomas
- Curas a base de hierbas respaldadas por la ciencia
- Reconocimiento de hierbas por imagen
- Mapa GPS interactivo: etiquete hierbas en la ubicación (próximamente)
- Leer publicaciones científicas relacionadas con su búsqueda
- Buscar hierbas medicinales por sus efectos.
- Organice sus intereses y manténgase al día con las noticias de investigación, ensayos clínicos y patentes.
Escriba un síntoma o una enfermedad y lea acerca de las hierbas que podrían ayudar, escriba una hierba y vea las enfermedades y los síntomas contra los que se usa.
* Toda la información se basa en investigaciones científicas publicadas.
